| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.953 | 0.002 | 0.953 | Aldehyde oxidase inhibitor | 0.483 0.035 CID_21309393 | ||
| 0.887 | 0.004 | 0.887 | Caspase 9 stimulant | 0.881 0.004 CID_21309393 | ||
| 0.825 | 0.003 | 0.907 | Histamine release inhibitor | 0.907 0.002 CID_21309393 | CID_21309393 | |
| 0.811 | 0.002 | 0.811 | Cystathionine beta-synthase inhibitor | 0.76 0.002 CID_21309393 | ||
| 0.812 | 0.004 | 0.829 | Free radical scavenger | 0.829 0.004 CID_21309393 | CID_21309393 | |
| 0.803 | 0.002 | 0.803 | Peroxidase inhibitor | 0.358 0.027 CID_21309393 | ||
| 0.803 | 0.002 | 0.803 | GABA C receptor rho-3 antagonist | 0.401 0.061 CID_21309393 | ||
| 0.803 | 0.004 | 0.87 | Antioxidant | 0.87 0.004 CID_21309393 | CID_21309393 | |
| 0.805 | 0.016 | 0.818 | Apoptosis agonist | 0.818 0.014 CID_21309393 | CID_21309393 | |
| 0.75 | 0.005 | 0.75 | 12-Lipoxygenase inhibitor | |||
| 0.749 | 0.007 | 0.749 | Aryl hydrocarbon receptor agonist | 0.293 0.063 CID_21309393 | ||
| 0.733 | 0.005 | 0.733 | Amyloid beta aggregation inhibitor | 0.499 0.014 CID_21309393 | ||
| 0.734 | 0.01 | 0.734 | 15-Lipoxygenase inhibitor | |||
| 0.704 | 0.004 | 0.769 | 5 Hydroxytryptamine release inhibitor | 0.769 0.004 CID_21309393 | CID_21309393 | |
| 0.694 | 0.005 | 0.694 | Caspase 3 stimulant | 0.57 0.012 CID_21309393 | ||
| 0.683 | 0.001 | 0.683 | Creatine kinase inhibitor | 0.259 0.005 CID_21309393 | ||
| 0.685 | 0.004 | 0.685 | Breast cancer-resistant protein inhibitor | 0.133 0.031 CID_21309393 | ||
| 0.627 | 0.005 | 0.876 | Monophenol monooxygenase inhibitor | 0.876 0.002 CID_21309393 | CID_21309393 | |
| 0.625 | 0.003 | 0.625 | Aldehyde dehydrogenase inhibitor | 0.585 0.004 CID_21309393 | ||
| 0.625 | 0.005 | 0.625 | MAO inhibitor | |||
| 0.659 | 0.041 | 0.873 | Alpha-glucosidase inhibitor | 0.873 0.01 CID_21309393 | CID_21309393 | |
| 0.62 | 0.004 | 0.62 | MAO A inhibitor | |||
| 0.641 | 0.027 | 0.881 | Transcription factor NF kappa B inhibitor | 0.881 0.008 CID_21309393 | CID_21309393 | |
| 0.615 | 0.004 | 0.615 | Interleukin 4 antagonist | 0.378 0.005 CID_21309393 | ||
| 0.592 | 0.002 | 0.592 | GABA C receptor rho-2 antagonist | 0.171 0.049 CID_21309393 | ||
| 0.633 | 0.045 | 0.845 | Antiinflammatory | 0.845 0.01 CID_21309393 | CID_21309393 | |
| 0.593 | 0.01 | 0.593 | Lipoxygenase inhibitor | 0.173 0.172 CID_21309393 | ||
| 0.586 | 0.004 | 0.586 | NADPH oxidase inhibitor | 0.504 0.004 CID_21309393 | ||
| 0.581 | 0.004 | 0.794 | Melanin inhibitor | 0.794 0.002 CID_21309393 | CID_21309393 | |
| 0.565 | 0.003 | 0.789 | Xanthine oxidase inhibitor | 0.789 0.002 CID_21309393 | CID_21309393 | |
| 0.562 | 0.005 | 0.562 | P-glycoprotein inhibitor | 0.407 0.015 CID_21309393 | ||
| 0.561 | 0.009 | 0.624 | Hypoxia-inducible factor 1 alpha inhibitor | 0.624 0.006 CID_21309393 | CID_21309393 | |
| 0.559 | 0.009 | 0.559 | Superoxide dismutase inhibitor | |||
| 0.549 | 0.005 | 0.802 | Amylase inhibitor | 0.802 0.002 CID_21309393 | CID_21309393 | |
| 0.546 | 0.005 | 0.564 | NOS3 expression enhancer | 0.564 0.004 CID_21309393 | CID_21309393 | |
| 0.53 | 0.002 | 0.53 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.162 0.015 CID_21309393 | ||
| 0.532 | 0.017 | 0.532 | Calcium channel L-type activator | 0.305 0.153 CID_21309393 | ||
| 0.516 | 0.006 | 0.518 | Topoisomerase II inhibitor | 0.518 0.006 CID_21309393 | CID_21309393 | |
| 0.525 | 0.017 | 0.623 | Apoptosis antagonist | 0.623 0.007 CID_21309393 | CID_21309393 | |
| 0.511 | 0.004 | 0.511 | Estrogen receptor beta antagonist | 0.111 0.045 CID_21309393 | ||
| 0.519 | 0.014 | 0.764 | Hypoglycemic | 0.764 0.004 CID_21309393 | CID_21309393 | |
| 0.511 | 0.008 | 0.511 | Pyruvate kinase inhibitor | 0.204 0.079 CID_21309393 | ||
| 0.506 | 0.005 | 0.506 | MAO B inhibitor | |||
| 0.503 | 0.016 | 0.614 | Antiamyloidogenic | 0.614 0.007 CID_21309393 | CID_21309393 | |
| 0.488 | 0.003 | 0.488 | Carbonic anhydrase III inhibitor | 0.306 0.005 CID_21309393 | ||
| 0.497 | 0.016 | 0.637 | Nitric oxide antagonist | 0.637 0.008 CID_21309393 | CID_21309393 | |
| 0.485 | 0.004 | 0.485 | Estrogen antagonist | 0.149 0.024 CID_21309393 | ||
| 0.486 | 0.005 | 0.486 | Acetylcholinesterase inhibitor | 0.161 0.049 CID_21309393 | ||
| 0.496 | 0.016 | 0.731 | Vasodilator, coronary | 0.731 0.004 CID_21309393 | CID_21309393 | |
| 0.502 | 0.023 | 0.622 | Spasmolytic | 0.622 0.011 CID_21309393 | CID_21309393 | |
| 0.474 | 0.012 | 0.474 | RNA-directed DNA polymerase inhibitor | 0.421 0.016 CID_21309393 | ||
| 0.463 | 0.004 | 0.832 | Beta glucuronidase inhibitor | 0.832 0.001 CID_21309393 | CID_21309393 | |
| 0.461 | 0.005 | 0.461 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.395 0.008 CID_21309393 | ||
| 0.454 | 0.004 | 0.454 | Topoisomerase II alpha inhibitor | 0.415 0.004 CID_21309393 | ||
| 0.45 | 0.005 | 0.45 | Chelator | 0.189 0.026 CID_21309393 | ||
| 0.449 | 0.007 | 0.493 | Lipid peroxidase inhibitor | 0.493 0.005 CID_21309393 | CID_21309393 | |
| 0.444 | 0.01 | 0.444 | Dual specificity phosphatase inhibitor | 0.129 0.122 CID_21309393 | ||
| 0.45 | 0.019 | 0.489 | DNA damaging | 0.489 0.015 CID_21309393 | CID_21309393 | |
| 0.476 | 0.047 | 0.476 | Prostaglandin dehydrogenase inhibitor | |||
| 0.444 | 0.017 | 0.51 | Vasodilator | 0.51 0.011 CID_21309393 | CID_21309393 | |
| 0.425 | 0.004 | 0.425 | Estrogen receptor alpha antagonist | 0.072 0.062 CID_21309393 | ||
| 0.468 | 0.05 | 0.718 | Antibacterial | 0.718 0.007 CID_21309393 | CID_21309393 | |
| 0.417 | 0.004 | 0.417 | Histidine decarboxylase inhibitor | 0.078 0.044 CID_21309393 | ||
| 0.419 | 0.012 | 0.643 | Hepatoprotectant | 0.643 0.004 CID_21309393 | CID_21309393 | |
| 0.411 | 0.004 | 0.411 | Carbonic anhydrase VI inhibitor | 0.226 0.01 CID_21309393 | ||
| 0.398 | 0.01 | 0.398 | Cholinergic | |||
| 0.385 | 0.003 | 0.385 | GABA C receptor antagonist | |||
| 0.395 | 0.015 | 0.395 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.393 | 0.014 | 0.393 | Dual specificity phosphatase 3 inhibitor | |||
| 0.394 | 0.02 | 0.394 | Transcription factor STAT inhibitor | 0.196 0.144 CID_21309393 | ||
| 0.378 | 0.004 | 0.378 | Carbonic anhydrase XV inhibitor | 0.088 0.087 CID_21309393 | ||
| 0.376 | 0.006 | 0.376 | 5-Lipoxygenase inhibitor | |||
| 0.374 | 0.004 | 0.375 | Nitric-oxide synthase stimulant | 0.375 0.004 CID_21309393 | CID_21309393 | |
| 0.365 | 0.003 | 0.365 | GABA C receptor rho-1 antagonist | 0.105 0.056 CID_21309393 | ||
| 0.365 | 0.007 | 0.4 | Alkaline phosphatase inhibitor | 0.4 0.005 CID_21309393 | CID_21309393 | |
| 0.361 | 0.007 | 0.361 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.364 | 0.011 | 0.364 | Protein-tyrosine phosphatase inhibitor | 0.29 0.021 CID_21309393 | ||
| 0.365 | 0.013 | 0.365 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.355 | 0.004 | 0.355 | Aldose reductase inhibitor | 0.279 0.005 CID_21309393 | ||
| 0.365 | 0.016 | 0.514 | Platelet adhesion inhibitor | 0.514 0.005 CID_21309393 | CID_21309393 | |
| 0.353 | 0.004 | 0.353 | Estrogen agonist | 0.167 0.01 CID_21309393 | ||
| 0.381 | 0.042 | 0.381 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.387 | 0.051 | 0.387 | Streptokinase A inhibitor | |||
| 0.339 | 0.003 | 0.339 | Multidrug resistance-associated protein 1 inhibitor | 0.275 0.004 CID_21309393 | ||
| 0.384 | 0.049 | 0.384 | 5 Hydroxytryptamine release stimulant | 0.227 0.102 CID_21309393 | ||
| 0.336 | 0.003 | 0.352 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.352 0.003 CID_21309393 | CID_21309393 | |
| 0.339 | 0.009 | 0.339 | Heat shock protein 90 alpha antagonist | |||
| 0.334 | 0.006 | 0.705 | Mediator release inhibitor | 0.705 0.003 CID_21309393 | CID_21309393 | |
| 0.334 | 0.013 | 0.502 | Protein kinase stimulant | 0.502 0.004 CID_21309393 | CID_21309393 | |
| 0.334 | 0.016 | 0.334 | Tubulin antagonist | |||
| 0.351 | 0.032 | 0.822 | Angiogenesis stimulant | 0.822 0.004 CID_21309393 | CID_21309393 | |
| 0.353 | 0.037 | 0.542 | Tumour necrosis factor alpha release inhibitor | 0.542 0.011 CID_21309393 | CID_21309393 | |
| 0.32 | 0.005 | 0.339 | Carbonic anhydrase XIII inhibitor | 0.339 0.005 CID_21309393 | CID_21309393 | |
| 0.315 | 0.003 | 0.315 | Xanthine dehydrogenase inhibitor | 0.174 0.005 CID_21309393 | ||
| 0.32 | 0.008 | 0.32 | Heat shock protein 90 antagonist | 0.144 0.081 CID_21309393 | ||
| 0.312 | 0.005 | 0.312 | Uric acid excretion stimulant | 0.287 0.005 CID_21309393 | ||
| 0.398 | 0.092 | 0.826 | Cyclophilin D inhibitor | 0.826 0.005 CID_21309393 | CID_21309393 | |
| 0.343 | 0.04 | 0.343 | Interleukin antagonist | 0.162 0.109 CID_21309393 | ||
| 0.328 | 0.026 | 0.328 | MAP kinase kinase 2 inhibitor | |||
| 0.339 | 0.038 | 0.339 | Insulysin inhibitor | |||
| 0.338 | 0.038 | 0.338 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.309 | 0.01 | 0.309 | Butyrylcholinesterase inhibitor | |||
| 0.314 | 0.015 | 0.314 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.329 | 0.031 | 0.479 | Cyclic AMP phosphodiesterase inhibitor | 0.479 0.008 CID_21309393 | CID_21309393 | |
| 0.312 | 0.015 | 0.331 | Neurotrophic factor enhancer | 0.331 0.012 CID_21309393 | CID_21309393 | |
| 0.305 | 0.01 | 0.305 | Protein-tyrosine phosphatase 1B inhibitor | 0.26 0.015 CID_21309393 | ||
| 0.296 | 0.003 | 0.296 | DOPA decarboxylase inhibitor | 0.127 0.038 CID_21309393 | ||
| 0.293 | 0.004 | 0.293 | Histone deacetylase SIRT1 stimulant | 0.251 0.005 CID_21309393 | ||
| 0.293 | 0.004 | 0.293 | Histone deacetylase stimulant | 0.251 0.005 CID_21309393 | ||
| 0.291 | 0.004 | 0.291 | CF transmembrane conductance regulator agonist | 0.224 0.012 CID_21309393 | ||
| 0.295 | 0.011 | 0.295 | Succinate dehydrogenase inhibitor | 0.161 0.093 CID_21309393 | ||
| 0.281 | 0.004 | 0.281 | Cyclin B3 inhibitor | |||
| 0.282 | 0.005 | 0.282 | Aromatase inhibitor | |||
| 0.289 | 0.018 | 0.289 | Bone formation stimulant | 0.19 0.038 CID_21309393 | ||
| 0.278 | 0.013 | 0.351 | Topoisomerase I inhibitor | 0.351 0.008 CID_21309393 | CID_21309393 | |
| 0.278 | 0.013 | 0.278 | Protein kinase (CK2) alpha inhibitor | |||
| 0.271 | 0.006 | 0.271 | Alcohol dehydrogenase inhibitor | 0.233 0.009 CID_21309393 | ||
| 0.291 | 0.03 | 0.563 | Non-steroidal antiinflammatory agent | 0.563 0.005 CID_21309393 | CID_21309393 | |
| 0.306 | 0.051 | 0.306 | Transcription factor STAT3 inhibitor | |||
| 0.278 | 0.023 | 0.458 | Interferon gamma antagonist | 0.458 0.008 CID_21309393 | CID_21309393 | |
| 0.258 | 0.004 | 0.258 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.281 | 0.027 | 0.281 | Mcl-1 antagonist | |||
| 0.259 | 0.006 | 0.259 | HIV-1 integrase (3'-Processing) inhibitor | 0.134 0.016 CID_21309393 | ||
| 0.304 | 0.051 | 0.304 | Dyrk kinase inhibitor | |||
| 0.26 | 0.009 | 0.26 | Telomerase inhibitor | 0.075 0.048 CID_21309393 | ||
| 0.254 | 0.003 | 0.254 | GABA B receptor antagonist | |||
| 0.257 | 0.007 | 0.257 | Protein kinase C zeta inhibitor | |||
| 0.247 | 0.004 | 0.247 | Estrogen receptor beta agonist | 0.109 0.01 CID_21309393 | ||
| 0.246 | 0.005 | 0.246 | Papain-like protease (SARS coronavirus) inhibitor | 0.129 0.063 CID_21309393 | ||
| 0.245 | 0.005 | 0.245 | Macrophage migration inhibitory factor inhibitor | |||
| 0.273 | 0.037 | 0.373 | DNA methyltransferase I inhibitor | 0.373 0.011 CID_21309393 | CID_21309393 | |
| 0.278 | 0.043 | 0.278 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.239 | 0.007 | 0.239 | HIV-1 integrase (Strand Transfer) inhibitor | 0.121 0.016 CID_21309393 | ||
| 0.25 | 0.021 | 0.25 | Cyclooxygenase 1 inhibitor | 0.166 0.049 CID_21309393 | ||
| 0.31 | 0.082 | 0.31 | Calcium channel activator | |||
| 0.255 | 0.029 | 0.255 | Tumour necrosis factor antagonist | |||
| 0.226 | 0.004 | 0.226 | Fatty acid synthase inhibitor | 0.124 0.006 CID_21309393 | ||
| 0.226 | 0.004 | 0.226 | Myeloperoxidase inhibitor | |||
| 0.246 | 0.027 | 0.246 | Cyclooxygenase inhibitor | 0.168 0.057 CID_21309393 | ||
| 0.222 | 0.005 | 0.242 | Heat shock protein 70 antagonist | 0.242 0.004 CID_21309393 | CID_21309393 | |
| 0.219 | 0.003 | 0.219 | D-Ala-D-Ala ligase inhibitor | |||
| 0.25 | 0.035 | 0.25 | Insulin sensitizer | 0.242 0.039 CID_21309393 | ||
| 0.246 | 0.034 | 0.246 | Amyloid beta precursor protein antagonist | |||
| 0.223 | 0.015 | 0.223 | Protein kinase (CK2) inhibitor | |||
| 0.214 | 0.007 | 0.214 | Keratolytic | |||
| 0.215 | 0.01 | 0.316 | Photosensitizer | 0.316 0.004 CID_21309393 | CID_21309393 | |
| 0.204 | 0.004 | 0.204 | DNA-dependent protein kinase inhibitor | |||
| 0.241 | 0.042 | 0.241 | I kappa B kinase epsilon inhibitor | |||
| 0.204 | 0.004 | 0.204 | Estrogen receptor alpha agonist | |||
| 0.263 | 0.065 | 0.263 | Gastrin inhibitor | 0.21 0.134 CID_21309393 | ||
| 0.292 | 0.094 | 0.71 | Antithrombotic | 0.71 0.008 CID_21309393 | CID_21309393 | |
| 0.26 | 0.064 | 0.26 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.22 | 0.025 | 0.395 | Hexokinase inhibitor | 0.395 0.004 CID_21309393 | CID_21309393 | |
| 0.202 | 0.009 | 0.469 | DNA repair enzyme inhibitor | 0.469 0.003 CID_21309393 | CID_21309393 | |
| 0.2 | 0.008 | 0.2 | Electron transport complex I inhibitor | 0.118 0.049 CID_21309393 | ||
| 0.197 | 0.006 | 0.197 | Alpha tubulin antagonist | |||
| 0.213 | 0.023 | 0.419 | Alkylator | 0.419 0.007 CID_21309393 | CID_21309393 | |
| 0.197 | 0.007 | 0.197 | CDC25A inhibitor | 0.09 0.034 CID_21309393 | ||
| 0.241 | 0.053 | 0.365 | DNA methylase inhibitor | 0.365 0.014 CID_21309393 | CID_21309393 | |
| 0.216 | 0.029 | 0.393 | Insulin secretagoues | 0.393 0.006 CID_21309393 | CID_21309393 | |
| 0.21 | 0.024 | 0.21 | Cholesterol synthesis inhibitor | 0.156 0.042 CID_21309393 | ||
| 0.203 | 0.018 | 0.544 | Cyclooxygenase 3 inhibitor | 0.544 0.003 CID_21309393 | CID_21309393 | |
| 0.19 | 0.005 | 0.19 | Carbonic anhydrase VII inhibitor | 0.083 0.012 CID_21309393 | ||
| 0.205 | 0.02 | 0.205 | Antibacterial (Helicobacter pylori) | 0.124 0.075 CID_21309393 | ||
| 0.271 | 0.088 | 0.552 | Immunostimulant | 0.552 0.022 CID_21309393 | CID_21309393 | |
| 0.208 | 0.026 | 0.225 | Mannose-6-phosphate isomerase inhibitor | 0.225 0.019 CID_21309393 | CID_21309393 | |
| 0.183 | 0.006 | 0.183 | Interleukin 5 antagonist | 0.143 0.013 CID_21309393 | ||
| 0.185 | 0.01 | 0.192 | Thioredoxin inhibitor | 0.192 0.009 CID_21309393 | CID_21309393 | |
| 0.206 | 0.032 | 0.347 | ATPase inhibitor | 0.347 0.004 CID_21309393 | CID_21309393 | |
| 0.205 | 0.032 | 0.205 | Neurotensin receptor agonist | |||
| 0.188 | 0.015 | 0.188 | Androgen antagonist | |||
| 0.202 | 0.03 | 0.202 | Cyclooxygenase 2 inhibitor | 0.14 0.062 CID_21309393 | ||
| 0.176 | 0.004 | 0.176 | Aryl hydrocarbon receptor antagonist | |||
| 0.182 | 0.012 | 0.182 | Prolactin inhibitor | |||
| 0.177 | 0.008 | 0.177 | Alcohol oxidase inhibitor | |||
| 0.179 | 0.013 | 0.179 | Urease inhibitor | |||
| 0.193 | 0.027 | 0.193 | Toll-Like receptor 2 antagonist | |||
| 0.179 | 0.015 | 0.54 | AMP-activated protein kinase stimulant | 0.54 0.003 CID_21309393 | CID_21309393 | |
| 0.199 | 0.034 | 0.317 | Alpha-N-acetylglucosaminidase inhibitor | 0.317 0.014 CID_21309393 | CID_21309393 | |
| 0.198 | 0.035 | 0.198 | Arachidonic acid antagonist | |||
| 0.318 | 0.156 | 0.318 | DNA polymerase beta inhibitor | |||
| 0.176 | 0.015 | 0.176 | Sphingomyelinase inhibitor | 0.148 0.025 CID_21309393 | ||
| 0.172 | 0.012 | 0.172 | Transcription factor STAT6 inhibitor | |||
| 0.202 | 0.042 | 0.202 | Phospholipase C inhibitor | 0.178 0.063 CID_21309393 | ||
| 0.195 | 0.038 | 0.195 | Death-associated protein kinase 2 inhibitor | |||
| 0.167 | 0.011 | 0.167 | Carbonic anhydrase V inhibitor | |||
| 0.165 | 0.011 | 0.165 | Glutamate decarboxylase inhibitor | |||
| 0.161 | 0.008 | 0.161 | Carbonic anhydrase VB inhibitor | |||
| 0.172 | 0.019 | 0.172 | TRPA1 agonist | 0.109 0.073 CID_21309393 | ||
| 0.222 | 0.069 | 0.226 | Psychostimulant | 0.226 0.068 CID_21309393 | CID_21309393 | |
| 0.157 | 0.005 | 0.157 | Protease activated receptor antagonist | |||
| 0.265 | 0.113 | 0.265 | Sodium/bile acid cotransporter inhibitor | 0.209 0.176 CID_21309393 | ||
| 0.309 | 0.157 | 0.309 | DNA directed DNA polymerase inhibitor | |||
| 0.156 | 0.008 | 0.156 | Thioredoxin reductase inhibitor | 0.09 0.04 CID_21309393 | ||
| 0.156 | 0.009 | 0.156 | Ornithine decarboxylase inhibitor | 0.129 0.02 CID_21309393 | ||
| 0.229 | 0.083 | 0.383 | DNA synthesis inhibitor | 0.383 0.024 CID_21309393 | CID_21309393 | |
| 0.164 | 0.021 | 0.164 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.153 | 0.01 | 0.153 | Carbonic anhydrase VA inhibitor | |||
| 0.166 | 0.024 | 0.363 | UDP-glucose 4-epimerase inhibitor | 0.363 0.007 CID_21309393 | CID_21309393 | |
| 0.182 | 0.041 | 0.519 | Hemostatic | 0.519 0.004 CID_21309393 | CID_21309393 | |
| 0.152 | 0.012 | 0.152 | Beta tubulin antagonist | |||
| 0.164 | 0.025 | 0.174 | Mucolytic | 0.174 0.021 CID_21309393 | CID_21309393 | |
| 0.144 | 0.006 | 0.144 | CD45 antagonist | |||
| 0.145 | 0.008 | 0.182 | Neuraminidase (influenza) inhibitor | 0.182 0.005 CID_21309393 | CID_21309393 | |
| 0.256 | 0.119 | 0.256 | Thyroid hormone antagonist | |||
| 0.171 | 0.034 | 0.171 | Farnesoid X receptor antagonist | |||
| 0.186 | 0.051 | 0.186 | Phospholipase A2 inhibitor | 0.152 0.072 CID_21309393 | ||
| 0.158 | 0.026 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 CID_21309393 | ||
| 0.16 | 0.029 | 0.313 | Antineoplastic antibiotic | 0.313 0.009 CID_21309393 | CID_21309393 | |
| 0.156 | 0.026 | 0.156 | Potassium channel (Ca-activated) activator | |||
| 0.133 | 0.003 | 0.133 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.182 | 0.053 | 0.28 | Interleukin 6 antagonist | 0.28 0.018 CID_21309393 | CID_21309393 | |
| 0.136 | 0.011 | 0.136 | HIV-1 integrase inhibitor | 0.074 0.043 CID_21309393 | ||
| 0.165 | 0.041 | 0.165 | Adenylate cyclase stimulant | |||
| 0.171 | 0.047 | 0.365 | Cell wall synthesis inhibitor | 0.365 0.007 CID_21309393 | CID_21309393 | |
| 0.145 | 0.021 | 0.145 | Anabolic | |||
| 0.156 | 0.033 | 0.459 | Expectorant | 0.459 0.004 CID_21309393 | CID_21309393 | |
| 0.127 | 0.009 | 0.151 | Neuraminidase inhibitor | 0.151 0.005 CID_21309393 | CID_21309393 | |
| 0.138 | 0.02 | 0.138 | CYP2A6 inhibitor | |||
| 0.122 | 0.004 | 0.122 | Transcription factor RelA inhibitor | |||
| 0.13 | 0.013 | 0.13 | Leukotriene antagonist | 0.123 0.015 CID_21309393 | ||
| 0.12 | 0.005 | 0.12 | Glutamate (mGluR7) antagonist | |||
| 0.159 | 0.044 | 0.182 | DNA polymerase I inhibitor | 0.182 0.034 CID_21309393 | CID_21309393 | |
| 0.24 | 0.125 | 0.24 | Thyroid hormone beta antagonist | |||
| 0.137 | 0.023 | 0.137 | Porphobilinogen synthase inhibitor | |||
| 0.136 | 0.023 | 0.136 | Aminoacyl-tRNA synthetase inhibitor | 0.101 0.044 CID_21309393 | ||
| 0.127 | 0.015 | 0.127 | Lipase inhibitor | 0.09 0.034 CID_21309393 | ||
| 0.131 | 0.021 | 0.145 | Interleukin 12 antagonist | 0.145 0.014 CID_21309393 | CID_21309393 | |
| 0.113 | 0.004 | 0.113 | Dopamine D5 agonist | |||
| 0.145 | 0.036 | 0.145 | GABA C receptor agonist | |||
| 0.116 | 0.007 | 0.116 | Heat shock protein 90 beta antagonist | |||
| 0.117 | 0.008 | 0.117 | Cyclin B1 inhibitor | |||
| 0.115 | 0.007 | 0.115 | Cyclin B2 inhibitor | |||
| 0.119 | 0.011 | 0.119 | Maillard reaction inhibitor | 0.081 0.024 CID_21309393 | ||
| 0.112 | 0.005 | 0.112 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.118 | 0.012 | 0.118 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.113 | 0.012 | 0.113 | CDC25B inhibitor | |||
| 0.108 | 0.008 | 0.108 | Topoisomerase II beta inhibitor | 0.082 0.013 CID_21309393 | ||
| 0.102 | 0.003 | 0.102 | ATP citrate lysase inhibitor | 0.033 0.021 CID_21309393 | ||
| 0.153 | 0.056 | 0.153 | MAP kinase kinase 4 inhibitor | |||
| 0.124 | 0.03 | 0.231 | Triose-phosphate isomerase inhibitor | 0.231 0.008 CID_21309393 | CID_21309393 | |
| 0.141 | 0.047 | 0.165 | Beta amyloid protein antagonist | 0.165 0.031 CID_21309393 | CID_21309393 | |
| 0.118 | 0.024 | 0.118 | Glutathione S-transferase inhibitor | |||
| 0.103 | 0.009 | 0.103 | Cyclin B inhibitor | |||
| 0.143 | 0.05 | 0.143 | Proteasome inhibitor | |||
| 0.095 | 0.003 | 0.095 | Estrogen-related receptor beta antagonist | |||
| 0.184 | 0.094 | 0.184 | Antimitotic | |||
| 0.101 | 0.012 | 0.101 | MAP kinase kinase 7 inhibitor | |||
| 0.118 | 0.029 | 0.217 | NADH dehydrogenase inhibitor | 0.217 0.009 CID_21309393 | CID_21309393 | |
| 0.106 | 0.019 | 0.106 | Estrogen-related receptor beta agonist | |||
| 0.109 | 0.024 | 0.109 | mTOR complex 2 inhibitor | |||
| 0.24 | 0.156 | 0.52 | Immunosuppressant | 0.52 0.028 CID_21309393 | CID_21309393 | |
| 0.106 | 0.023 | 0.106 | Leukotriene synthesis inhibitor | |||
| 0.181 | 0.099 | 0.181 | Histone acetyltransferase inhibitor | |||
| 0.086 | 0.005 | 0.086 | Cholesterol esterase inhibitor | 0.047 0.035 CID_21309393 | ||
| 0.089 | 0.01 | 0.089 | Potassium channel Kv1.3 blocker | |||
| 0.091 | 0.012 | 0.091 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.102 | 0.025 | 0.102 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.089 | 0.012 | 0.089 | Cyclin D1 inhibitor | |||
| 0.11 | 0.033 | 0.11 | Phosphodiesterase 4D inhibitor | |||
| 0.128 | 0.052 | 0.128 | Interleukin 8 antagonist | |||
| 0.079 | 0.004 | 0.079 | Protein kinase (CK2) beta inhibitor | |||
| 0.092 | 0.018 | 0.092 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.091 | 0.018 | 0.091 | GABA receptor antagonist | |||
| 0.11 | 0.036 | 0.158 | Phosphodiesterase 6D inhibitor | 0.158 0.008 CID_21309393 | CID_21309393 | |
| 0.159 | 0.087 | 0.159 | Catenin beta inhibitor | |||
| 0.14 | 0.069 | 0.14 | Neurotrophic factor | 0.126 0.086 CID_21309393 | ||
| 0.086 | 0.015 | 0.128 | Carbonic anhydrase XIV inhibitor | 0.128 0.006 CID_21309393 | CID_21309393 | |
| 0.179 | 0.108 | 0.179 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.09 | 0.02 | 0.09 | Protein kinase C eta inhibitor | 0.049 0.045 CID_21309393 | ||
| 0.083 | 0.014 | 0.14 | Leukotriene B4 antagonist | 0.14 0.005 CID_21309393 | CID_21309393 | |
| 0.077 | 0.009 | 0.077 | Leukotriene C antagonist | |||
| 0.122 | 0.056 | 0.196 | DNA intercalator | 0.196 0.027 CID_21309393 | CID_21309393 | |
| 0.083 | 0.017 | 0.083 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.073 | 0.007 | 0.122 | Arginase inhibitor | 0.122 0.003 CID_21309393 | CID_21309393 | |
| 0.216 | 0.151 | 0.463 | Cholesterol antagonist | 0.463 0.038 CID_21309393 | CID_21309393 | |
| 0.071 | 0.007 | 0.083 | Neuraminidase (Influenza A) inhibitor | 0.083 0.005 CID_21309393 | CID_21309393 | |
| 0.145 | 0.082 | 0.309 | Diuretic | 0.309 0.021 CID_21309393 | CID_21309393 | |
| 0.097 | 0.034 | 0.12 | Na+ K+ transporting ATPase inhibitor | 0.12 0.016 CID_21309393 | CID_21309393 | |
| 0.082 | 0.022 | 0.082 | Beta 3 adrenoreceptor antagonist | |||
| 0.083 | 0.024 | 0.083 | Purinergic P2X1 antagonist | |||
| 0.097 | 0.039 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.088 | 0.03 | 0.088 | Potassium channel large-conductance Ca-activated activator | |||
| 0.134 | 0.076 | 0.134 | Cytokine production inhibitor | |||
| 0.092 | 0.034 | 0.119 | T cell inhibitor | 0.119 0.015 CID_21309393 | CID_21309393 | |
| 0.093 | 0.036 | 0.093 | Cathepsin G inhibitor | |||
| 0.082 | 0.025 | 0.155 | Carbonic anhydrase XII inhibitor | 0.155 0.012 CID_21309393 | CID_21309393 | |
| 0.111 | 0.054 | 0.178 | Toll-Like receptor 4 antagonist | 0.178 0.01 CID_21309393 | CID_21309393 | |
| 0.069 | 0.013 | 0.069 | Adenylate cyclase 1 inhibitor | |||
| 0.13 | 0.076 | 0.13 | Interleukin 1 antagonist | |||
| 0.062 | 0.008 | 0.062 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.213 | 0.161 | 0.213 | Vasodilator, peripheral | |||
| 0.089 | 0.036 | 0.178 | Phosphofructokinase-1 inhibitor | 0.178 0.014 CID_21309393 | CID_21309393 | |
| 0.108 | 0.056 | 0.108 | Adenylate kinase inhibitor | |||
| 0.078 | 0.027 | 0.078 | Glutamate (mGluR6) antagonist | |||
| 0.119 | 0.068 | 0.119 | Adenylate cyclase inhibitor | |||
| 0.072 | 0.022 | 0.072 | Sphingosine kinase inhibitor | |||
| 0.068 | 0.019 | 0.068 | Dihydroorotate oxidase inhibitor | |||
| 0.059 | 0.01 | 0.059 | DNA gyrase subunit A inhibitor | 0.043 0.029 CID_21309393 | ||
| 0.092 | 0.045 | 0.092 | Inducible nitric-oxide synthase inhibitor | |||
| 0.102 | 0.054 | 0.102 | MAP kinase kinase 1 inhibitor | |||
| 0.061 | 0.014 | 0.061 | Purinergic P2X4 antagonist | |||
| 0.096 | 0.049 | 0.096 | NMDA receptor antagonist | |||
| 0.124 | 0.079 | 0.124 | Vanilloid 1 agonist | 0.115 0.1 CID_21309393 | ||
| 0.067 | 0.022 | 0.067 | Ryanodine receptor antagonist | |||
| 0.125 | 0.081 | 0.125 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.082 | 0.038 | 0.088 | Phosphodiesterase VI inhibitor | 0.088 0.03 CID_21309393 | CID_21309393 | |
| 0.05 | 0.007 | 0.05 | Dopamine autoreceptor agonist | |||
| 0.083 | 0.04 | 0.083 | Adenosine A3 receptor antagonist | |||
| 0.051 | 0.009 | 0.051 | Leukotriene C4 antagonist | |||
| 0.112 | 0.071 | 0.144 | Microtubule formation inhibitor | 0.144 0.041 CID_21309393 | CID_21309393 | |
| 0.152 | 0.111 | 0.152 | Anesthetic general | 0.142 0.122 CID_21309393 | ||
| 0.079 | 0.039 | 0.079 | CDK1/cyclin B1 inhibitor | |||
| 0.101 | 0.061 | 0.101 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.075 | 0.036 | 0.075 | Dopamine D1 antagonist | |||
| 0.07 | 0.031 | 0.07 | Androgen agonist | |||
| 0.096 | 0.058 | 0.096 | Bile acid receptor antagonist | |||
| 0.072 | 0.035 | 0.072 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.058 | 0.024 | 0.058 | CXC chemokine 1 receptor antagonist | |||
| 0.079 | 0.044 | 0.079 | GABA B receptor agonist | |||
| 0.042 | 0.009 | 0.042 | Estrone sulfatase inhibitor | |||
| 0.058 | 0.026 | 0.113 | Glucose-6-phosphate translocase inhibitor | 0.113 0.005 CID_21309393 | CID_21309393 | |
| 0.078 | 0.046 | 0.078 | Glutamate dehydrogenase inhibitor | |||
| 0.058 | 0.026 | 0.058 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.061 | 0.03 | 0.061 | GABA A receptor antagonist | |||
| 0.073 | 0.042 | 0.073 | Protein kinase C beta inhibitor | |||
| 0.079 | 0.048 | 0.079 | GABA aminotransferase inhibitor | 0.072 0.058 CID_21309393 | ||
| 0.054 | 0.024 | 0.073 | Glucose-6-phosphate isomerase inhibitor | 0.073 0.011 CID_21309393 | CID_21309393 | |
| 0.047 | 0.018 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.065 | 0.036 | 0.065 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.08 | 0.051 | 0.102 | Interferon agonist | 0.102 0.027 CID_21309393 | CID_21309393 | |
| 0.143 | 0.114 | 0.143 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.102 | 0.074 | 0.102 | 5 Hydroxytryptamine 3A agonist | |||
| 0.041 | 0.013 | 0.041 | Catechol O-methyltransferase inhibitor | |||
| 0.064 | 0.036 | 0.064 | Heme oxygenase stimulant | |||
| 0.068 | 0.041 | 0.068 | Beta adrenoreceptor antagonist | |||
| 0.056 | 0.03 | 0.056 | Aconitate hydratase inhibitor | |||
| 0.127 | 0.102 | 0.36 | Thrombolytic | 0.36 0.015 CID_21309393 | CID_21309393 | |
| 0.073 | 0.049 | 0.073 | Glycine receptor agonist | 0.067 0.062 CID_21309393 | ||
| 0.089 | 0.066 | 0.112 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.112 0.044 CID_21309393 | CID_21309393 | |
| 0.056 | 0.032 | 0.056 | mTOR inhibitor | |||
| 0.052 | 0.03 | 0.052 | Squalene epoxidase inhibitor | |||
| 0.043 | 0.021 | 0.043 | Retinoic acid alpha receptor agonist | |||
| 0.041 | 0.02 | 0.041 | Vanilloid 3 antagonist | |||
| 0.06 | 0.04 | 0.06 | Phosphatidylinositol kinase inhibitor | |||
| 0.041 | 0.021 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.028 | 0.01 | 0.028 | Glutamate (mGluR1a) agonist | |||
| 0.028 | 0.01 | 0.03 | Leukotriene B4 receptor 2 antagonist | 0.03 0.009 CID_21309393 | CID_21309393 | |
| 0.09 | 0.072 | 0.09 | Aminopeptidase B inhibitor | |||
| 0.065 | 0.048 | 0.065 | Dopamine agonist | |||
| 0.126 | 0.109 | 0.126 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.056 | 0.039 | 0.058 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.058 0.037 CID_21309393 | CID_21309393 | |
| 0.043 | 0.026 | 0.043 | Cathepsin L2 inhibitor | |||
| 0.043 | 0.028 | 0.043 | Heme oxygenase inhibitor | |||
| 0.035 | 0.019 | 0.035 | Protein kinase C beta I inhibitor | 0.032 0.027 CID_21309393 | ||
| 0.035 | 0.02 | 0.035 | Estrogen-related receptor alpha antagonist | |||
| 0.04 | 0.025 | 0.04 | NMDA receptor subunit 3A antagonist | |||
| 0.022 | 0.008 | 0.037 | Antibiotic Anthracycline-like | 0.037 0.003 CID_21309393 | CID_21309393 | |
| 0.089 | 0.075 | 0.089 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.028 | 0.015 | 0.115 | Sodium/glucose cotransporter 2 inhibitor | 0.115 0.002 CID_21309393 | CID_21309393 | |
| 0.104 | 0.09 | 0.104 | MAP kinase kinase inhibitor | |||
| 0.031 | 0.018 | 0.031 | Leukotriene B4 receptor 1 antagonist | 0.028 0.019 CID_21309393 | ||
| 0.038 | 0.026 | 0.038 | Glutamate (mGluR8) agonist | |||
| 0.06 | 0.049 | 0.087 | Nitric oxide donor | 0.087 0.016 CID_21309393 | CID_21309393 | |
| 0.027 | 0.016 | 0.027 | Thyroid hormone agonist | |||
| 0.269 | 0.258 | 0.269 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.022 | 0.012 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.057 | 0.047 | 0.057 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.017 | 0.007 | 0.017 | Antibiotic Tetracycline-like | |||
| 0.028 | 0.02 | 0.028 | Estrogen-related receptor gamma antagonist | |||
| 0.026 | 0.017 | 0.102 | Sodium/glucose cotransporter inhibitor | 0.102 0.003 CID_21309393 | CID_21309393 | |
| 0.047 | 0.038 | 0.047 | Bombesin 2 receptor antagonist | |||
| 0.19 | 0.182 | 0.342 | Angiogenesis inhibitor | 0.342 0.074 CID_21309393 | CID_21309393 | |
| 0.077 | 0.069 | 0.077 | Ca(v)3.1 blocker | |||
| 0.032 | 0.024 | 0.032 | Glutamate (mGluR3) agonist | |||
| 0.044 | 0.036 | 0.044 | Adenosine deaminase inhibitor | |||
| 0.062 | 0.056 | 0.062 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.02 | 0.014 | 0.02 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.039 | 0.034 | 0.039 | Carbonic anhydrase IV inhibitor | |||
| 0.052 | 0.047 | 0.052 | Adenosine A1 receptor antagonist | |||
| 0.05 | 0.047 | 0.05 | Argininosuccinate synthase inhibitor | |||
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.037 | 0.034 | 0.037 | Liver X receptor alpha agonist | |||
| 0.039 | 0.036 | 0.039 | NMDA receptor subunit 3B antagonist | |||
| 0.054 | 0.052 | 0.054 | Carbonic anhydrase inhibitor | 0.054 0.051 CID_21309393 | ||
| 0.029 | 0.027 | 0.029 | Sirtuin 2 inhibitor | |||
| 0.058 | 0.058 | 0.073 | Interferon inducer | 0.073 0.031 CID_21309393 | CID_21309393 | |
| 0.036 | 0.035 | 0.036 | Dopamine D5 antagonist | |||
| 0.021 | 0.021 | 0.076 | Protein 30S ribosomal subunit inhibitor | 0.076 0.004 CID_21309393 | CID_21309393 | |
| 0.023 | 0.023 | 0.039 | Vanilloid 2 agonist | 0.039 0.004 CID_21309393 | CID_21309393 | |
| 0.157 | 0.16 | 0.295 | Interleukin agonist | 0.295 0.05 CID_21309393 | CID_21309393 | |
| 0.044 | 0.048 | 0.055 | Cytokine production stimulant | 0.055 0.019 CID_21309393 | CID_21309393 | |
| 0.047 | 0.053 | 0.147 | Heparanase inhibitor | 0.147 0.003 CID_21309393 | CID_21309393 | |
| 0.014 | 0.021 | 0.021 | Telomerase stimulant | 0.021 0.007 CID_21309393 | CID_21309393 | |
| 0.018 | 0.029 | 0.029 | Dopamine D1 agonist | 0.029 0.009 CID_21309393 | CID_21309393 | |
| 0.159 | 0.17 | 0.396 | Peptidyltransferase inhibitor | 0.396 0.007 CID_21309393 | CID_21309393 | |
| 0.065 | 0.087 | 0.108 | Glycine receptor antagonist | 0.108 0.026 CID_21309393 | CID_21309393 | |
| 0.028 | 0.062 | 0.048 | Carbonic anhydrase IX inhibitor | 0.048 0.044 CID_21309393 | CID_21309393 | |
| 0.026 | 0.061 | 0.082 | Antibiotic Aminoglycoside-like | 0.082 0.004 CID_21309393 | CID_21309393 | |
| 0.13 | 0.169 | 0.358 | Platelet antagonist | 0.358 0.036 CID_21309393 | CID_21309393 | |
| 0.037 | 0.08 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.013 CID_21309393 | CID_21309393 | |
| 0.026 | 0.082 | 0.071 | Mannosidase inhibitor | 0.071 0.011 CID_21309393 | CID_21309393 | |
| 0.005 | 0.065 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_21309393 | CID_21309393 | |
| 0.045 | 0.106 | 0.067 | Lipocortins synthesis agonist | 0.067 0.025 CID_21309393 | CID_21309393 | |
| 0.039 | 0.108 | 0.057 | Transcription factor AP-1 inhibitor | 0.057 0.05 CID_21309393 | CID_21309393 | |
| 0.019 | 0.105 | 0.063 | Phosphorylase inhibitor | 0.063 0.023 CID_21309393 | CID_21309393 | |
| 0.014 | 0.102 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 CID_21309393 | CID_21309393 | |
| 0.04 | 0.129 | 0.067 | Adenine nucleotide translocase inhibitor | 0.067 0.018 CID_21309393 | CID_21309393 | |
| 0.108 | 0.201 | 0.15 | CC chemokine 6 receptor antagonist | 0.15 0.022 CID_21309393 | CID_21309393 | |
| 0.051 | 0.15 | 0.102 | Falcipain 2 inhibitor | 0.102 0.051 CID_21309393 | CID_21309393 | |
| 0.053 | 0.154 | 0.104 | Falcipain inhibitor | 0.104 0.052 CID_21309393 | CID_21309393 | |
| 0.026 | 0.129 | 0.377 | Selectin antagonist | 0.377 0.004 CID_21309393 | CID_21309393 | |
| 0.102 | 0.206 | 0.307 | Hypolipemic | 0.307 0.047 CID_21309393 | CID_21309393 | |
| 0.034 | 0.138 | 0.051 | Factor III inhibitor | 0.051 0.033 CID_21309393 | CID_21309393 | |
| 0.023 | 0.14 | 0.047 | Microtubule stabilization | 0.047 0.032 CID_21309393 | CID_21309393 | |
| 0.002 | 0.134 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_21309393 | CID_21309393 | |
| 0.148 | 0.302 | 0.414 | Interleukin 2 agonist | 0.414 0.024 CID_21309393 | CID_21309393 | |
| 0.018 | 0.185 | 0.108 | Protein 50S ribosomal subunit inhibitor | 0.108 0.011 CID_21309393 | CID_21309393 | |
| 0.026 | 0.212 | 0.064 | DNA gyrase inhibitor | 0.064 0.043 CID_21309393 | CID_21309393 | |
| 0.039 | 0.228 | 0.122 | ATPase (Vacuolar H+) inhibitor | 0.122 0.019 CID_21309393 | CID_21309393 | |
| 0.04 | 0.368 | 0.131 | Transcription factor NF kappa B stimulant | 0.131 0.021 CID_21309393 | CID_21309393 | |
| 0.031 | 0.463 | 0.238 | Cell adhesion inhibitor | 0.238 0.017 CID_21309393 | CID_21309393 | |
| 0.011 | 0.485 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.011 CID_21309393 | CID_21309393 | |
| 0.05 | 0.576 | 0.406 | Immunomodulator | 0.406 0.042 CID_21309393 | CID_21309393 | |
| 0.014 | 0.544 | 0.11 | Cell adhesion molecule inhibitor | 0.11 0.029 CID_21309393 | CID_21309393 | |
| 0.014 | 0.626 | 0.205 | Anticoagulant | 0.205 0.051 CID_21309393 | CID_21309393 | |
| 0.013 | 0.676 | 0.072 | Factor IXa inhibitor | 0.072 0.019 CID_21309393 | CID_21309393 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |